{
  "id": "5c6638717c78d69471000012",
  "type": "yesno",
  "question": "Is celecoxib effective for treatment of amyotrophic lateral sclerosis?",
  "ideal_answer": "No. In clinical trial celecoxib did not have a beneficial effect on research subjects with ALS, and it was safe. A biological effect of celecoxib was not demonstrated in the cerebrospinal fluid. Further studies of celecoxib at a dosage of 800 mg/day in ALS were not recommended.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/16802291"
  ],
  "snippets": [
    {
      "text": "NTERPRETATION: At the dosage studied, celecoxib did not have a beneficial effect on research subjects with ALS, and it was safe. A biological effect of celecoxib was not demonstrated in the cerebrospinal fluid. Further studies of celecoxib at a dosage of 800 mg/day in ALS are not warranted.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16802291",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Prostaglandin E(2) levels in cerebrospinal fluid were not elevated at baseline and did not decline with treatment.<br><b>INTERPRETATION</b>: At the dosage studied, celecoxib did not have a beneficial effect on research subjects with ALS, and it was safe.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16802291",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}